Spectrascience Inc (SCIE) financial statements (2021 and earlier)

Company profile

Business Address 11568 SORRENTO VALLEY ROAD
SAN DIEGO, CA 92121
State of Incorp. MN
Fiscal Year End December 31
SIC 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments00000
Cash and cash equivalents00000
Receivables00 0 
Inventory, net of allowances, customer advances and progress billings00000
Inventory00000
Deferred costs 0000
Prepaid expense and other current assets0
Other undisclosed current assets0000 
Total current assets:01111
Noncurrent Assets
Inventory, Noncurrent 0   
Property, plant and equipment 0000
Intangible assets, net (including goodwill)11122
Intangible assets, net (excluding goodwill)11122
Total noncurrent assets:11122
TOTAL ASSETS:12222
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities42211
Accounts payable11111
Accrued liabilities21100
Debt66421
Derivative instruments and hedges, liabilities11112
Due to related parties0    
Other undisclosed current liabilities 00  
Total current liabilities:119754
Noncurrent Liabilities
Long-term debt and lease obligation1 43 
Long-term debt, excluding current maturities1 43 
Liabilities, other than long-term debt    2
Derivative instruments and hedges, liabilities    2
Total noncurrent liabilities:1 432
Total liabilities:1291186
Stockholders' equity
Stockholders' equity attributable to parent, including:(11)(7)(4)(3)(2)
Common stock94222
Additional paid in capital3538403735
Retained earnings (accumulated deficit)(54)(49)(46)(41)39
Other undisclosed stockholders' equity attributable to parent0 00(77)
Total stockholders' equity:(11)(7)(4)(3)(2)
Other undisclosed liabilities and equity00(4)(3)(2)
TOTAL LIABILITIES AND EQUITY:12222

Income statement (P&L) ($ in millions)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues00 00
Cost of revenue(0)(0) (0)(0)
Other undisclosed gross profit  0  
Gross profit:(0)0000
Operating expenses(2)(2)(3)(3)(4)
Operating loss:(2)(2)(3)(3)(4)
Nonoperating expense(2)(1)(2)(0)(5)
Investment income, nonoperating    2
Other nonoperating expense(0)(0)(0)(0)(0)
Interest and debt expense00(0)(0)(2)
Loss before gain (loss) on sale of properties:(4)(3)(5)(3)(11)
Other undisclosed net income  002
Net loss:(4)(3)(4)(3)(9)
Other undisclosed net loss attributable to parent(0)(0)   
Net loss attributable to parent:(4)(4)(4)(3)(9)
Other undisclosed net income available to common stockholders, basic    18
Net income (loss) available to common stockholders, basic:(4)(4)(4)(3)9
Dilutive securities, effect on basic earnings per share    14
Other undisclosed net loss available to common stockholders, diluted    (11)
Net income (loss) available to common stockholders, diluted:(4)(4)(4)(3)11

Comprehensive Income ($ in millions)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(4)(3)(4)(3)(9)
Comprehensive loss, net of tax, attributable to parent:(4)(3)(4)(3)(9)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: